Novel target class with dual action in inflammatory disorders Discovered and validated on Galapagos' target discovery platform Fully owned and proprietary Mechelen, Belgium; 7 January 2019, 7.30 CET - Galapagos NV (Euronext & NASDAQ: GLPG) …
KYOTO, Japan, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Nidec Corporation (TSE: 6594; OTC US: NJDCY) (the “Company”) today announced the status of the Company’s own share repurchase under its ongoing repurchase plan resolved at a meeting of the Board of Directors …
Basel, Switzerland, January 07, 2019 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today the unaudited preliminary revenue for the financial year 2018. Total revenue is expected to increase by 31% over 2017 to approx. CHF 133 million (FYR 2017: CHF …
2019 Corporate Calendar Fiat Chrysler Automobiles N.V. (NYSE: FCAU / MTA: FCA) announced today the following corporate calendar for year 20191: Earnings Releases7 February 2019 - Group Results for Fourth Quarter and Full Year 20183 May 2019 - Group Results …
News Highlights Unveils displays across consumer portfolio, including the world’s first 15-inch laptop with an AMOLED display1 and the world’s first Quantum Dot on glass display2. Launches Bordeaux Burgundy version of the Spectre Folio convertible. Extends …
Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate Phase 1 interim results showed an excellent immunogenicity profile after a single-shot vaccination and an acceptable safety profile, supporting further development 100% …
Lead candidate CYAD-01 continues to demonstrate encouraging clinical activity in THINK Phase 1 trial with a new complete response (CR) observed in patient with myelodysplastic syndrome (MDS) Key focus to accelerate the development of CYAD-01 for the …
LAS VEGAS, Jan. 06, 2019 (GLOBE NEWSWIRE) -- CES -- NVIDIA today announced that the world’s top manufacturers are bringing to market a record number of laptops based on its revolutionary Turing GPU architecture — including the fastest, thinnest and …
QUEBEC CITY, Jan. 07, 2019 (GLOBE NEWSWIRE) -- LeddarTech, an industry leader providing the most versatile and scalable auto and mobility LiDAR platform, announces the availability of production samples of the LeddarCore LCA2 system-on-chip (SoC), which …
LAS VEGAS, Jan. 06, 2019 (GLOBE NEWSWIRE) -- CES -- NVIDIA today announced the NVIDIA® GeForce® RTX 2060, putting revolutionary Turing architecture GPUs within the reach of tens of millions PC gamers worldwide. The RTX 2060 GPU delivers exceptional …
BURNABY, British Columbia, Jan. 06, 2019 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today provided a corporate update and outlined its anticipated key milestone events in 2019. Dr. Simon …
Ascension Healthcare plc Appointment of Dr Gavin Ling as Chief Medical Officer LONDON, January 7, 2019 – Ascension Healthcare plc (“Ascension” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and commercialising …
TYSONS, Va. and LAS VEGAS, Jan. 06, 2019 (GLOBE NEWSWIRE) -- Alarm.com (Nasdaq: ALRM), the leading platform for the intelligently connected property, has introduced Smart Signal, a mobile app emergency signaling feature that enables property owners to …
TYSONS, Va. and LAS VEGAS, Jan. 06, 2019 (GLOBE NEWSWIRE) -- Alarm.com, the leading platform for the intelligently connected property, today announced at CES a newly expanded Wellness product line focused on well-being and health. These new independent …
— FY18 Product and Service Revenue of $83.5 million, Exceeding High-End of Guidance — — Generated Pre-Orders for More Than 30 GeoMx™ Digital Spatial Profilers — SEATTLE, Jan. 06, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a …
LAS VEGAS, Jan. 06, 2019 (GLOBE NEWSWIRE) -- Nuheara, the smart-hearing company, today announced the launch of IQbuds™ MAX, the first intelligent hearing buds with Active Noise Cancellation. IQbuds MAX deliver natural sound with advanced noise cancellation …
MENLO PARK, Calif., Jan. 06, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases, today reviewed recent progress and provided an …
HONG KONG, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, issued …
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 06, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that its Board of Directors has approved a …
06 days 05:57:53
